Cancer Plus

About the Journal

Editor-in-Chief: Dr Chong Li

ISSN: 2661-3840 (Online) 

          2661-3832 (Print) 

Publishing Frequency: Quarterly（four issues per year）

Article Processing Charges (APC): Click here for more details

Publishing Model: Open Access

Collaborating Institution：Medical Immunodiagnosis Research Center, Institute of Biophysics, Chinese Academy of Sciences

Online Submissions

Cancer Plus is a new research journal dedicated to the publication of findings in cancer research. This journal is a joint collaboration between Whioce Publishing Pte Ltd (Singapore) and the Chinese Academy of Sciences (China).

We encourage researchers to publish the latest findings in cancer research, including preliminary results, repeated argumentation studies and negative results. The journal welcomes various types of submissions e.g. research papers, clinical research reports, review articles, etc.

Cancer Plus is indexed by CNKI and Google Scholar. Currently, Cancer Plus is working towards being indexed by BIOSIS, Scopus, PubMed and Science Citation Index Expanded (SCIE)

Recent Articles

Review Articles

Abstract
PDF
Research Progress on Anti-angiogenesis Drugs in Hepatocellular Carcinoma
Yihui Yang, Liwen Ren, Hong Yang, Binbin Ge, Wan Li, Yumin Wang, Hongquan Wang, Guanhua Du, Bo Tang, Jinhua Wang
CP 2021, 3(2); doi: 10.18063/cp.v3i2.319
94 Views, 31 PDF Downloads

Review Articles

Abstract
PDF
Transferrin Receptor Serves as a Potential Target for Cancer Therapy
Tian Tang, Jinhan Yang, Siyuan Jing
CP 2021, 3(2); doi: 10.18063/cp.v3i2.317
87 Views, 12 PDF Downloads

Review Articles

Abstract
PDF
Research Progress on the Abnormal Expression of Galectin-3 and p16 in Cervical Cancer
Minghan Yang, Qiushuang Ma, Jinku Zhang
CP 2021, 2(3); doi: 10.18063/c+.v2i3.309
198 Views, 22 PDF Downloads

Reports

Abstract
PDF
Primary Small-Cell Neuroendocrine Carcinoma of the Kidney with Urothelial Carcinoma: A Case Series and Literature Review
Runlin Feng, Yanping Tao, Wen Zhang, Jihong Deng, Shuangyue Liu
CP 2021, 3(1); doi: 10.18063/cp.v3i1.307
78 Views, 24 PDF Downloads

Review Articles

Abstract
PDF
The Role of FGFR3 in the Diagnosis and Treatment of Bladder Cancer: A Review
Hairong Wei, Weiming Wan, Hui Zhan, Jiansong Wang, Jian Chen
CP 2021, 3(1); doi: 10.18063/cp.v3i1.302
138 Views, 32 PDF Downloads

Reports

Abstract
PDF
Conversion Therapy for Locally Advanced Pancreatic Cancer: A Case Series and Literature Review
Mingxing Wang, Yunyun Xu, Min Yang, Dingyi Jiang, Yunwang Chen, Jiahong Jiang, Zheling Chen, Liu Yang
CP 2021, 2(4); doi: 10.18063/cp.v2i4.298
88 Views, 36 PDF Downloads

Announcements

 

Cancer+ Renamed as Cancer Plus

  
Staring March 2021, Cancer+ will be officially renamed as Cancer Plus. All articles that are assigned to Volume 3 (2021) and thereafter will be published under the new journal title – Cancer Plus. The journal was renamed to increase the visibility of the journal on the Internet. Specifically, the plus sign “+” in the original journal title can hardly be recognized by many browsers, complicating the simple step of searching the journal online. For that reason, Whioce Publishing decides to rename Cancer+ as Cancer Plus.  
Posted: 2021-03-11
 
More Announcements...